Membrane-bound interleukin-21 and CD137 ligand induce functional human natural killer cells from peripheral blood mononuclear cells through STAT-3 activation

Highly activated and expanded natural killer cells for multiple myeloma immunotherapy

(2012) T. K. Garg et al.   HAEMATOLOGICA

Identification of microRNA transcriptome involved in human natural killer cell activation

(2012) Xin Liu et al.   IMMUNOLOGY LETTERS

Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells

(2012) Cecele J. Denman et al.   PLoS One

Natural Killer Cell Differentiation from Hematopoietic Stem Cells: A Comparative Analysis of Heparin- and Stromal Cell–Supported Methods

(2011) Steven A. Dezell et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Clinical-Grade Generation of Active NK Cells from Cord Blood Hematopoietic Progenitor Cells for Immunotherapy Using a Closed-System Culture Process

(2011) Jan Spanholtz et al.   PLoS One

High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy

(2010) Jan Spanholtz et al.   PLoS One

Replicative potential of human natural killer cells

(2009) Hiroyuki Fujisaki et al.   BRITISH JOURNAL OF HAEMATOLOGY

Expansion of Highly Cytotoxic Human Natural Killer Cells for Cancer Cell Therapy

(2009) H. Fujisaki et al.   CANCER RESEARCH

Clinical-grade ex vivo-expanded human natural killer cells up-regulate activating receptors and death receptor ligands and have enhanced cytolytic activity against tumor cells

(2009) Maria Berg et al.   CYTOTHERAPY

Comparative study of four fluorescent probes for evaluation of natural killer cell cytotoxicity assays

(2008) D CHOLUJOVA et al.   IMMUNOBIOLOGY